JAK2V617F mutation as a marker of a latent myeloproliferative disorder in a patient with Budd-Chiari syndrome and factor V Leiden mutation

Thrombosis and Haemostasis

Volumn 98, Issue 3, 2007, Pages 681-682

  Plumé, Gema ^a   Vayá, Amparo ^a   Ferrando, Fernando ^a   Mira, Yolanda ^a   Orbis, Francisco ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; BLOOD CLOTTING FACTOR 5 LEIDEN; ENOXAPARIN; JANUS KINASE 2;

ADULT; ARTICLE; ASCITES; BUDD CHIARI SYNDROME; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; DOPPLER ECHOGRAPHY; FEMALE; GENE MUTATION; GENETIC CODE; GENETIC RISK; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERNAL JUGULAR VEIN; KIDNEY FAILURE; LABORATORY TEST; LIVER FAILURE; MUTATIONAL ANALYSIS; MYELOPROLIFERATIVE DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURGICAL DRAINAGE; VEIN THROMBOSIS;

ADULT; FACTOR V; FATAL OUTCOME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATIC VEIN THROMBOSIS; HUMANS; JANUS KINASE 2; MUTATION; MYELOPROLIFERATIVE DISORDERS; PEDIGREE; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RISK FACTORS;

EID: 34548682992     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-04-0239     Document Type: Article

References (18)

1. Menon KVN, Shah V, Kamath PS. The Budd-Chiari Syndrome. N Engl J Med 2004; 350: 578-585.
2. Denninger MH, Chaït Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000; 31: 587-591.
3. Janssen HLA, Meinardi JR, Vleggaar FP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000; 96: 2364-2368.
4. Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative diseases. Lancet 2005; 365: 1054-1061.
5. Kralovics R, Passamonti F, Buser AS, ct al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779-1790.
6. Vardiman JW, Harris NL, Brunnung RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292-2302.
7. Patel RK, Lea NC, Heneghan MA, et al. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology 2006; 130: 2031-2038.
8. Deltenre P, Denninger MH, Hillaire S, et al. Factor V Leiden related Budd-Chiari syndrome. Gut 2001; 48: 264-268.
9. Mahmoud AEA, Elias E, Beauchamp N, et al. Prevalence of factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 1997; 40: 798-800.
10. Souto JC, Coll I, Llobet D, et al. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb Haemost 1998; 80: 366-369.
11. Vayá A, Mira Y, Mateo J, et al. Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk. Thromb Haemost 2003; 89: 452-457.
12. Schafer AI. Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia. Blood 2006; 107: 4214-4221
13. Primignani M, Barosi G, Bergamaschi G, et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 2006; 44: 1528-1534.
14. Campbell PJ, Scott LM, Buck G, et al. Definition of subtipes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2V617F mutation status: a prospective study. Lancet 2005; 366: 1945-1953.
15. Colaizzo D, Amitrano L, Iannaccone L, et al. Gain of function gene mutations and venous thromboembolism: distinct roles in different clinical settings. J Med Genet 2007; prepub online.
16. Colaizzo D, Amitrano L, Tiscia GL, et al. The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. J Thromb Haemost 2007; 5: 55-61.
17. Murad SD, Valla DC, de Groen PC, et al. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol 2006; 101: 83-90.
18. Baba-Ahmed M, Le Gal G, Couturaud F, et al. High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis. Thromb Haemost 2007; 97: 171-175.